The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1282-1285 October 17, 2002 Number 16
NextNext

Salmeterol for the Prevention of High-Altitude Pulmonary Edema

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Voelkel, N. F.
-Related Article
by Sartori, C.
-PubMed Citation
To the Editor: Sartori and colleagues (May 23 issue)1 demonstrate the marked benefits of salmeterol in the secondary prevention of high-altitude pulmonary edema. The authors propose that this benefit occurs through changes in pulmonary transepithelial sodium transport rather than hemodynamic effects, because salmeterol did not alter the heart rate or peak pulmonary pressures.

However, the authors did not assess the nasal transepithelial potential difference at high altitude, nor did they determine the effect of salmeterol administration on this gradient. Furthermore, there was no measurement of mean pulmonary pressure, cardiac output, central filling pressures, or systemic blood pressure. In addition, only . . . [Full Text of this Article]


This article has been cited by other articles:


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.